Home | About the Medical Center | Donate or Volunteer | Contact Us
Home > Clinical Trials >
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of an Experimental Anti-Fungal versus an FDA-Approved Anti-Fungal for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi
A Prospective, Randomized Trial Comparing the Efficacy of an Experimental (Not Approved by the FDA) Anti-Fungal and an FDA-Approved Anti-Fungal in Combination to that of the FDA-Approved Anti-Fungal Alone When Used for Primary Therapy of Proven or Probable Invasive Aspergillosis
Comparing the Effectiveness of an Experimental Drug with an FDA Approved Drug in the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)
Drug Study for the Prevention of Cytomegalovirus (CMV) in Orthotopic Liver Transplant Patients
Drug Study for the Treatment of Foot Infections (With or Without an Infection to the Bone) in Subjects with Diabetes
Notice of Privacy Practices | Legal Disclaimer | Contact Us | Site Map
Call HealthLink toll-free at 1-888-UCH-0200. Copyright © 2008 University of Chicago Medical Center. All rights reserved.
